- More than 180 participants from over 40 countries complete ‘2023 Introductory Course for Biologics Development and Manufacturing’ to receive the certificate
- East African Community Regional Centre of Excellence for Vaccines, Immunization and Health Supply Chain Management (EAC RCE-VIHSCM) supported 15 trainees for travel from EAC member states to attend the course
The International Vaccine Institute (IVI) successfully completed the ‘2023 Introductory Course for Biologics Development and Manufacturing’ on June 30 and awarded the certificate to more than 180 trainees from over 40 countries including 27 from Korea.
The course, hosted by the Korean Ministry of Health and Welfare (MOHW) and organized by IVI, took place at Seoul National University Siheung Campus in Gyeonggi Province from June 19-30 to help strengthen LMICs’ capabilities in local production of vaccines and biologics, address vaccine inequity, and enhance pandemic preparedness. The two-week course is part of the Global Training Hub for Biomanufacturing (GTH-B) that IVI has been implementing in collaboration with MOHW since last year.